Advertisement
AMTX vs GEVO
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMTX is a StrongBuy and GEVO is a Buy.
AMTX's RSI Indicator recovers from oversold territory
The RSI Indicator for AMTX moved out of oversold territory on November 04, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 48 similar instances when the indicator left oversold territory. In 41 of the 48 cases the stock moved higher. This puts the odds of a move higher at 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 69 cases where AMTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 05, 2026. You may want to consider a long position or call options on AMTX as a result. In 70 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for AMTX just turned positive on November 05, 2026. Looking at past instances where AMTX's MACD turned positive, the stock continued to rise in 33 of 39 cases over the following month. The odds of a continued upward trend are 85%.
Following a +50.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMTX advanced for three days, in 187 of 232 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
AMTX moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMTX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
AMTX broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AMTX entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 76 (best 1 - 100 worst), indicating slightly worse than average price growth. AMTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.363) is normal, around the industry mean (2.284). P/E Ratio (-1.884) is within average values for comparable stocks, (-17.137). AMTX's Projected Growth (PEG Ratio) (19.780) is very high in comparison to the industry average of (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.555) is also within normal values, averaging (48.960).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
GEVO in upward trend: 10-day moving average moved above 50-day moving average on November 12, 2026
The 10-day moving average for GEVO crossed bullishly above the 50-day moving average on November 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on GEVO as a result. In 73 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for GEVO just turned positive on October 27, 2026. Looking at past instances where GEVO's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
GEVO moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +33.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where GEVO advanced for three days, in 187 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
GEVO broke above its upper Bollinger Band on November 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for GEVO entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 22 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 38 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.258) is normal, around the industry mean (2.284). P/E Ratio (-1.544) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (2.012) is also within normal values, averaging (48.960).
The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. GEVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GEVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
AMTX | GEVO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 47 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | 38 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 87 | 98 | |
PRICE GROWTH RATING 1..100 | 76 | 38 | |
P/E GROWTH RATING 1..100 | 59 | 22 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GEVO's Valuation (38) in the Chemicals Specialty industry is somewhat better than the same rating for AMTX (94). This means that GEVO’s stock grew somewhat faster than AMTX’s over the last 12 months.
GEVO's Profit vs Risk Rating (100) in the Chemicals Specialty industry is in the same range as AMTX (100). This means that GEVO’s stock grew similarly to AMTX’s over the last 12 months.
AMTX's SMR Rating (87) in the Chemicals Specialty industry is in the same range as GEVO (98). This means that AMTX’s stock grew similarly to GEVO’s over the last 12 months.
GEVO's Price Growth Rating (38) in the Chemicals Specialty industry is somewhat better than the same rating for AMTX (76). This means that GEVO’s stock grew somewhat faster than AMTX’s over the last 12 months.
GEVO's P/E Growth Rating (22) in the Chemicals Specialty industry is somewhat better than the same rating for AMTX (59). This means that GEVO’s stock grew somewhat faster than AMTX’s over the last 12 months.
| AMTX | GEVO | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 85% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 83% | 1 day ago 81% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 78% |
| MACD ODDS (%) | 1 day ago 85% | 1 day ago 77% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Advances ODDS (%) | 9 days ago 81% | 1 day ago 84% |
| Declines ODDS (%) | 1 day ago 89% | N/A |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AMTX’s FA Score shows that 0 FA rating(s) are green while GEVO’s FA Score has 1 green FA rating(s).
- AMTX’s FA Score: 0 green, 5 red.
- GEVO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AMTX’s TA Score shows that 5 TA indicator(s) are bullish while GEVO’s TA Score has 5 bullish TA indicator(s).
- AMTX’s TA Score: 5 bullish, 4 bearish.
- GEVO’s TA Score: 5 bullish, 4 bearish.
Price Growth
AMTX (@Chemicals: Specialty) experienced а -23.12% price change this week, while GEVO (@Chemicals: Specialty) price change was +52.46% for the same time period.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -1.17%. For the same industry, the average monthly price growth was -4.83%, and the average quarterly price growth was -10.65%.
Reported Earning Dates
AMTX is expected to report earnings on Mar 11, 2027.
GEVO is expected to report earnings on Mar 11, 2027.
Industries' Descriptions
@Chemicals: Specialty (-1.17% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
Advertisement
AMTX and
Correlation & Price change
A.I.dvisor indicates that over the last year, AMTX has been loosely correlated with GEVO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMTX jumps, then GEVO could also see price increases.
| Ticker / NAME | Correlation To AMTX | 1D Price Change % | ||
|---|---|---|---|---|
| AMTX | 100% | -7.32% | ||
| GEVO - AMTX | 35% Loosely correlated | +2.20% | ||
| DINO - AMTX | 31% Poorly correlated | +0.93% | ||
| PARR - AMTX | 31% Poorly correlated | +1.19% | ||
| CLNE - AMTX | 31% Poorly correlated | +5.32% | ||
| WLK - AMTX | 30% Poorly correlated | -1.72% | ||
More | ||||
GEVO and
Correlation & Price change
A.I.dvisor indicates that over the last year, GEVO has been loosely correlated with RPC. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GEVO jumps, then RPC could also see price increases.
| Ticker / NAME | Correlation To GEVO | 1D Price Change % | ||
|---|---|---|---|---|
| GEVO | 100% | +2.20% | ||
| RPC - GEVO | 38% Loosely correlated | -3.05% | ||
| ASPI - GEVO | 36% Loosely correlated | -4.59% | ||
| SSL - GEVO | 28% Poorly correlated | +1.78% | ||
| GPRE - GEVO | 28% Poorly correlated | +0.15% | ||
| BCPC - GEVO | 28% Poorly correlated | -0.55% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| JCHI | 49.39 | N/A | N/A |
| JPMorgan Active China ETF Active China ETF (JCHI) | |||
| ENZL | 45.65 | -0.15 | -0.33% |
| iShares MSCI New Zealand ETF (ENZL) | |||
| DIA | 522.47 | -1.97 | -0.38% |
| State Street SPDR Dow Jones Industrial Average ETF Trust (DIA) | |||
| MTBA | 47.21 | -0.21 | -0.43% |
| Simplify MBS ETF (MTBA) | |||
| JHPI | 21.59 | -0.11 | -0.52% |
| John Hancock Preferred Income ETF (JHPI) | |||